Gabelli & Co Investment Advisers’s NxStage Medical Inc. NXTM Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-417,045	Closed	-$11.9M	–	198
2018 Q4	$11.9M	Buy	417,045 +62,500	+18%	+$1.78M	1.69%	21
2018 Q3	$9.89M	Buy	354,545 +14,002	+4%	+$394K	0.99%	29
2018 Q2	$9.5M	Sell	340,543 -9,287	-3%	-$249K	1.18%	26
2018 Q1	$8.7M	Buy	349,830 +13,240	+4%	+$322K	1.1%	25
2017 Q4	$8.16M	Buy	336,590 +80,308	+31%	+$2.12M	1.08%	26
2017 Q3	$7.07M	Buy	+256,282	New	+$6.83M	0.82%	31

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Gabelli & Co Investment Advisers's NXTM Position: Q1 2019 in Review

Gabelli & Co Investment Advisers sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 417,045 shares — an estimated $11.9M sold.

Gabelli & Co Investment Advisers first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $11.9M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Gabelli & Co Investment Advisers reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 417,045 NxStage Medical Inc. shares in Q1 2019, an estimated $11.9M.
Gabelli & Co Investment Advisers first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
Gabelli & Co Investment Advisers's NxStage Medical Inc. position peaked at $11.9M in Q4 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2019, filed 2 May 2019.